Skip to main content
Erschienen in: Heart and Vessels 3/2013

01.05.2013 | Original Article

Utility of measuring C-reactive protein for prediction of in-hospital events in patients with acute aortic dissection

verfasst von: Norihito Okina, Masanao Ohuchida, Tomohiro Takeuchi, Tomoki Fujiyama, Akira Satoh, Teruo Sakamoto, Hisashi Adachi, Tsutomu Imaizumi

Erschienen in: Heart and Vessels | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Controlling blood pressure is essential for prevention of events after acute aortic dissection (AAD). However, in some instances a cardiac event occurs despite controlled blood pressure, and its prediction is difficult. We continuously monitored C-reactive protein (CRP) in patients receiving medical treatment for AAD and retrospectively examined the utility of CRP measurement for prediction of in-hospital events. Five hundred and eight patients were diagnosed as having AAD between 1993 and 2009, 240 of whom underwent antihypertensive medical therapy. These subjects were 156 males and 84 females, average age 67.4 years, with 68 cases of Stanford type A and 172 cases of Stanford type B. C-reactive protein was measured in all patients daily until a peak; subsequently, CRP was measured 2–3 times per week following the peak until discharge. In the event-free group CRP demonstrated a peak on the 4th day after the onset (average 13.7 mg/dl), then gradually decreased to an average of 4.6 mg/dl 4 weeks later, displaying a “gradual decay” pattern. Despite controlled systolic arterial pressure of approximately 120 mmHg, 7 of 68 Stanford A cases (10.3 %) and 8 of 172 Stanford B cases (4.7 %) developed cardiovascular events. The group characterized by events exhibited a CRP pattern distinct from that of the event-free group, i.e., prolonged elevation and/or re-elevation. We demonstrated that the CRP pattern could provide information regarding prediction of cardiovascular events. Prolonged elevation or re-elevation of CRP may indicate the necessity of (1) application of computed tomography or magnetic resonance imaging, (2) more rigorous blood pressure management, or (3) early surgical intervention.
Literatur
1.
2.
Zurück zum Zitat Harris KM, Strauss CE, Eagle KA, Hirsch AT, Isselbacher EM, Tsai TT, Shiran H, Fattori R, Evangelista A, Cooper JV, Montgomery DG, Froehlich JB, Nienaber CA, International Registry of Acute Aortic Dissection (IRAD) Investigators (2011) Correlates of delayed recognition and treatment of acute type A aortic dissection: the International Registry of Acute Aortic Dissection (IRAD). Circulation 124:1911–1918PubMedCrossRef Harris KM, Strauss CE, Eagle KA, Hirsch AT, Isselbacher EM, Tsai TT, Shiran H, Fattori R, Evangelista A, Cooper JV, Montgomery DG, Froehlich JB, Nienaber CA, International Registry of Acute Aortic Dissection (IRAD) Investigators (2011) Correlates of delayed recognition and treatment of acute type A aortic dissection: the International Registry of Acute Aortic Dissection (IRAD). Circulation 124:1911–1918PubMedCrossRef
3.
Zurück zum Zitat Trimarchi S, Eagle KA, Nienaber CA, Rampoldi V, Jonker FH, De Vincentiis C, Frigiola A, Menicanti L, Tsai T, Froehlich J, Evangelista A, Montgomery D, Bossone E, Cooper JV, Li J, Deeb MG, Meinhardt G, Sundt TM, Isselbacher EM, International Registry of Acute Aortic Dissection Investigators (2010) Role of age in acute type A aortic dissection outcome: report from the International Registry of Acute Aortic Dissection (IRAD). J Thorac Cardiovasc Surg 140:784–789PubMedCrossRef Trimarchi S, Eagle KA, Nienaber CA, Rampoldi V, Jonker FH, De Vincentiis C, Frigiola A, Menicanti L, Tsai T, Froehlich J, Evangelista A, Montgomery D, Bossone E, Cooper JV, Li J, Deeb MG, Meinhardt G, Sundt TM, Isselbacher EM, International Registry of Acute Aortic Dissection Investigators (2010) Role of age in acute type A aortic dissection outcome: report from the International Registry of Acute Aortic Dissection (IRAD). J Thorac Cardiovasc Surg 140:784–789PubMedCrossRef
4.
Zurück zum Zitat Booher AM, Isselbacher EM, Nienaber CA, Froehlich JB, Trimarchi S, Cooper JV, Demertzis S, Ramanath VS, Januzzi JL, Harris KM, O’Gata PT, Sundt TM, Pyeritz RE, Eagle KA, International Registry of Acute Aortic Dissection (IRAD) Investigators (2011) Ascending thoracic aorta dimension and outcomes in acute type B dissection (from the IRAD). Am J Cardiol 107:315–320PubMedCrossRef Booher AM, Isselbacher EM, Nienaber CA, Froehlich JB, Trimarchi S, Cooper JV, Demertzis S, Ramanath VS, Januzzi JL, Harris KM, O’Gata PT, Sundt TM, Pyeritz RE, Eagle KA, International Registry of Acute Aortic Dissection (IRAD) Investigators (2011) Ascending thoracic aorta dimension and outcomes in acute type B dissection (from the IRAD). Am J Cardiol 107:315–320PubMedCrossRef
5.
Zurück zum Zitat Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE, Eagle KA, Hermann LK, Isselbacher EM, Kazerooni EA, Kouchoukos NT, Lytle BW, Milewicz DM, Reich DL, Sen S, Shinn JA, Sevensson LG, Williams DM (2010) 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease. Circulation 121:e266–e369PubMedCrossRef Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE, Eagle KA, Hermann LK, Isselbacher EM, Kazerooni EA, Kouchoukos NT, Lytle BW, Milewicz DM, Reich DL, Sen S, Shinn JA, Sevensson LG, Williams DM (2010) 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease. Circulation 121:e266–e369PubMedCrossRef
6.
Zurück zum Zitat Tsai TT, Evangelista A, Nienaber CA, Myrmel T, Meinhardt G, Cooper JV, Smith DE, Suzuki T, Fattori R, Llovet A, Froehlich J, Hutchison S, Distante A, Sundt T, Beckman J, Januzzi JL, Isselbacher EM, Eagle KA (2007) Partial thrombosis of the false lumen in patients with acute type B aortic dissection. N Engl J Med 357:349–359PubMedCrossRef Tsai TT, Evangelista A, Nienaber CA, Myrmel T, Meinhardt G, Cooper JV, Smith DE, Suzuki T, Fattori R, Llovet A, Froehlich J, Hutchison S, Distante A, Sundt T, Beckman J, Januzzi JL, Isselbacher EM, Eagle KA (2007) Partial thrombosis of the false lumen in patients with acute type B aortic dissection. N Engl J Med 357:349–359PubMedCrossRef
7.
Zurück zum Zitat Trimarchi S, Eagle KA, Nienaber CA, Pyeritz RE, Jonker FH, Suzuki T, O’Gara PT, Hutchinson SJ, Rampoldi V, Grassi V, Bossone E, Muhs BE, Evangelista A, Tsai TT, Froehlich JB, Cooper JV, Montgomery D, Meinhardt G, Myrmel T, Upchurch GR, Sundt TM, Isselbacher EM, International Registry of Acute Aortic Dissection (IRAD) Investigators (2010) Importance of refractory pain and hypertension in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation 122:1283–1289PubMedCrossRef Trimarchi S, Eagle KA, Nienaber CA, Pyeritz RE, Jonker FH, Suzuki T, O’Gara PT, Hutchinson SJ, Rampoldi V, Grassi V, Bossone E, Muhs BE, Evangelista A, Tsai TT, Froehlich JB, Cooper JV, Montgomery D, Meinhardt G, Myrmel T, Upchurch GR, Sundt TM, Isselbacher EM, International Registry of Acute Aortic Dissection (IRAD) Investigators (2010) Importance of refractory pain and hypertension in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation 122:1283–1289PubMedCrossRef
8.
Zurück zum Zitat Baikoussis NG, Apostolakis EE, Siminelakis SN, Papadopoulos GS, Goudevenos J (2009) Intramural haematoma of the thoracic aorta: who’s to be alerted the cardiologist or the cardiac surgeon? J Cardiothorac Surg 4:54. doi:10.1186/1749-8090-4-54 PubMedCrossRef Baikoussis NG, Apostolakis EE, Siminelakis SN, Papadopoulos GS, Goudevenos J (2009) Intramural haematoma of the thoracic aorta: who’s to be alerted the cardiologist or the cardiac surgeon? J Cardiothorac Surg 4:54. doi:10.​1186/​1749-8090-4-54 PubMedCrossRef
9.
Zurück zum Zitat Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JP, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ, For the JUPITER Study Group (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359:2195–2207PubMedCrossRef Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JP, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ, For the JUPITER Study Group (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359:2195–2207PubMedCrossRef
10.
Zurück zum Zitat Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, Engstrom G, Persson M, Smith JG, Magnusson M, Christensson A, Struck J, Morgenthaler N, Bergmann A, Pencina M, Wang TJ (2009) Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 302:49–57PubMedCrossRef Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, Engstrom G, Persson M, Smith JG, Magnusson M, Christensson A, Struck J, Morgenthaler N, Bergmann A, Pencina M, Wang TJ (2009) Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 302:49–57PubMedCrossRef
11.
Zurück zum Zitat Weng CW, Chou CH, Huang YY, Lin CC, Liu YW, Tsai WC (2010) Increased C-reactive protein is associated with future development of diabetes mellitus in essential hypertension patients. Heart Vessels 25:386–391PubMedCrossRef Weng CW, Chou CH, Huang YY, Lin CC, Liu YW, Tsai WC (2010) Increased C-reactive protein is associated with future development of diabetes mellitus in essential hypertension patients. Heart Vessels 25:386–391PubMedCrossRef
12.
Zurück zum Zitat Quarck R, Nawrot T, Meyns B, Delcroix M (2009) C-reactive protein. A new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol 53:1211–1218PubMedCrossRef Quarck R, Nawrot T, Meyns B, Delcroix M (2009) C-reactive protein. A new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol 53:1211–1218PubMedCrossRef
13.
Zurück zum Zitat Ranasinghe AM, Bonser RS (2010) Biomarkers in acute aortic dissection and other aortic syndrome. J Am Coll Cardiol 56:1535–1541PubMedCrossRef Ranasinghe AM, Bonser RS (2010) Biomarkers in acute aortic dissection and other aortic syndrome. J Am Coll Cardiol 56:1535–1541PubMedCrossRef
14.
Zurück zum Zitat Jo Y, Anzai T, Ueno K, Kaneko H, Kohno T, Sugano Y, Maekawa Y, Yoshikawa T, Shimizu H, Yozu R, Ogawa S (2010) Re-elevation of D-dimer as a predictor of re-dissection and venous thromboembolism after Stanford type B acute aortic dissection. Heart Vessels 25:509–514PubMedCrossRef Jo Y, Anzai T, Ueno K, Kaneko H, Kohno T, Sugano Y, Maekawa Y, Yoshikawa T, Shimizu H, Yozu R, Ogawa S (2010) Re-elevation of D-dimer as a predictor of re-dissection and venous thromboembolism after Stanford type B acute aortic dissection. Heart Vessels 25:509–514PubMedCrossRef
15.
16.
Zurück zum Zitat Jo Y, Anzai T, Sugano Y, Naito K, Ueno K, Kohno T, Yoshikawa T, Ogawa S (2008) Early use of beta-blockers attenuates systemic inflammatory response and lung oxygenation impairment after distal type acute aortic dissection. Heart Vessels 23:334–340PubMedCrossRef Jo Y, Anzai T, Sugano Y, Naito K, Ueno K, Kohno T, Yoshikawa T, Ogawa S (2008) Early use of beta-blockers attenuates systemic inflammatory response and lung oxygenation impairment after distal type acute aortic dissection. Heart Vessels 23:334–340PubMedCrossRef
17.
Zurück zum Zitat Girdauskas E, Kuntze T, Borger MA, Falk V, Mohr FW (2009) Surgical risk of preoperative malperfusion in acute type A aortic dissection. J Thorac Cardiovasc Surg 138:1363–1369PubMedCrossRef Girdauskas E, Kuntze T, Borger MA, Falk V, Mohr FW (2009) Surgical risk of preoperative malperfusion in acute type A aortic dissection. J Thorac Cardiovasc Surg 138:1363–1369PubMedCrossRef
18.
Zurück zum Zitat Suzuki T, Isselbacher EM, Nienaber CA, Pyeritz RE, Eagle KA, Tsai TT, Cooper JV, Januzzi JL, Braverman AC, Montgomery DG, Fattori R, Pape L, Harris KM, Booher A, Oh JK, Peterson M, Ramanath VS, Froehlich JB (2012) Type-selective benefits of medications in treatment of acute aortic dissection (from the International Registry of Acute Aortic Dissection [IRAD]). Am J Cardiol 109:122–127PubMedCrossRef Suzuki T, Isselbacher EM, Nienaber CA, Pyeritz RE, Eagle KA, Tsai TT, Cooper JV, Januzzi JL, Braverman AC, Montgomery DG, Fattori R, Pape L, Harris KM, Booher A, Oh JK, Peterson M, Ramanath VS, Froehlich JB (2012) Type-selective benefits of medications in treatment of acute aortic dissection (from the International Registry of Acute Aortic Dissection [IRAD]). Am J Cardiol 109:122–127PubMedCrossRef
19.
Zurück zum Zitat Schillinger M, Domanovits H, Bayegan K, Holzenbein T, Grabenwoger M, Thoenissen J, Roggla M, Mullner M (2002) C-reactive protein and mortality in patients with acute aortic disease. Intensive Care Med 28:740–750PubMedCrossRef Schillinger M, Domanovits H, Bayegan K, Holzenbein T, Grabenwoger M, Thoenissen J, Roggla M, Mullner M (2002) C-reactive protein and mortality in patients with acute aortic disease. Intensive Care Med 28:740–750PubMedCrossRef
20.
Zurück zum Zitat Sakakura K, Kubo N, Ako J, Wada H, Fujiwara N, Funayama H, Ikeda N, Nakamura T, Sugawara Y, Yasu T, Kawakami M, Momomura S (2010) Peak C-reactive protein level predicts long-term outcomes in type B acute aortic dissection. Hypertension 55:422–429PubMedCrossRef Sakakura K, Kubo N, Ako J, Wada H, Fujiwara N, Funayama H, Ikeda N, Nakamura T, Sugawara Y, Yasu T, Kawakami M, Momomura S (2010) Peak C-reactive protein level predicts long-term outcomes in type B acute aortic dissection. Hypertension 55:422–429PubMedCrossRef
21.
Zurück zum Zitat Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K (2003) Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives. Circulation 107:1401–1406PubMedCrossRef Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K (2003) Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives. Circulation 107:1401–1406PubMedCrossRef
22.
Zurück zum Zitat Ueda T, Kai H, Imaizumi T (2012) Losartan/hydrochlorothiazide combination vs. high-dose losartan in patients with morning hypertension—a prospective, randomized, open-labeled, parallel-group, multicenter trial. Hypertens Res. doi:10.1038/hr.2012.27 Ueda T, Kai H, Imaizumi T (2012) Losartan/hydrochlorothiazide combination vs. high-dose losartan in patients with morning hypertension—a prospective, randomized, open-labeled, parallel-group, multicenter trial. Hypertens Res. doi:10.​1038/​hr.​2012.​27
Metadaten
Titel
Utility of measuring C-reactive protein for prediction of in-hospital events in patients with acute aortic dissection
verfasst von
Norihito Okina
Masanao Ohuchida
Tomohiro Takeuchi
Tomoki Fujiyama
Akira Satoh
Teruo Sakamoto
Hisashi Adachi
Tsutomu Imaizumi
Publikationsdatum
01.05.2013
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 3/2013
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-012-0257-2

Weitere Artikel der Ausgabe 3/2013

Heart and Vessels 3/2013 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.